Huan Meng

Dr. Huan Meng

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

17 November 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
HMHuan Meng
Huan Meng
JZJianglin Zhou
Jianglin Zhou
MWMingyu Wang
Mingyu Wang
MZMei Zheng
Mei Zheng
YXYa ling Xing
Ya ling Xing
YWYajie Wang
Yajie Wang
The interaction of viruses with hosts is complex, especially so with the antiviral immune systems of hosts, and the underlying mechanisms remain perplexing. Infection with SARS-CoV-2 may result in cytokine syndrome in the later stages, reflecting the activation of the antiviral immune response. However, viruses also encode molecules to negatively regulate the antiviral immune systems of hosts to achieve immune evasion and benefit viral replication during the early stage of infection. It has been observed that the papain-like protease (PLP) encoded by coronavirus could negatively regulate the host’s IFNβ innate immunity. In this study, we first found that eight inflammasome-related genes were downregulated in CD14+ monocytes from COVID-19 patients. Subsequently, we observed that SARS-CoV-2 PLP negatively regulated the NLRP3 inflammasome pathway, inhibited the secretion of IL-1β, and decreased the caspase-1-mediated pyroptosis of human monocytes. The mechanisms for this may arise because PLP coimmunoprecipitates with ASC, reduces ASC ubiquitination, and inhibits ASC oligomerization and the formation of ASC specks. These findings suggest that PLP may inhibit strong immune defenses and provide the maximum advantage for viral replication. This research may allow us to better understand the flex function of CoV-encoding proteases and provide a new perspective on the innate immune responses against SARS-CoV-2 and other viruses.

24 January 2023
Verified
Preprint
Open access
PDF file
HMHuan Meng
Huan Meng
JZJianglin Zhou
Jianglin Zhou
XCXiaojuan Chen
Xiaojuan Chen
MWMingYu Wang
MingYu Wang
MZMei Zheng
Mei Zheng
YWYajie Wang
Yajie Wang
The perplexing innate immune response induced by SARS-CoV-2 infection remains inadequate uncovered. Previous studies showed that coronavirus papain-like protease (PLP) could evade type I interferons mediated innate immune responses. In this study, we found the inflammasome genes (NLRP3, NLRP6, PYCARD, IL1B, IL18, TRIM31, FBXL2, MARCH7) were down-regulated in CD14+ monocytes from COVID-19 patients. Secondly, we found that SARS-CoV-2 PLP may act on the NLRP3 inflammasome pathway. PLP may interact with ASC and interrupt ASC oligomerization by reducing the K48-linked and K63-linked ubiquitination of ASC, so that the excessive activation of the NLRP3 inflammatory pathway might be inhibited and the release of IL-1β was blocked. Thirdly, SARS-CoV-2 PLP negatively regulated the pyroptosis of host cells, which was mediated by caspase-1, the key regulator of the NLRP3 inflammasome pathway. In general, SARS-CoV-2 PLP avoids the excessive immune defenses in the early stage of virus infection, which provides the maximum advantage for virus replication. These insights uncover the flex function of CoV encoding proteases. Furthermore, this research may provide a new vision of COVID-19 epidemic prevention and new possibilities for new therapies.